Article: Nicotinamide Riboside Improves Mitophagy and Reduces Neuroinflammation in Ataxia Telangiectasia: Preclinical Findings

PrevNext
Ataxia Telangiectasia Mitochondrial Health Neurological Health Preclinical

Nicotinamide Riboside Improves Mitophagy and Reduces Neuroinflammation in Ataxia Telangiectasia: Preclinical Findings

Synopsis

In the premature aging disease ataxia telangiectasia (A-T), cells show mitochondrial dysfunction and a senescence state that causes inflammation (SASP). This is linked to buildup of damaged mitochondria and DNA in the cell cytoplasm, activating inflammatory pathways via STING. Boosting NAD+ with nicotinamide riboside (NR) helps clear damaged mitochondria through mitophagy, which depends on the protein PINK1. NR treatment reduced brain inflammation, prevented nerve cell loss, and improved movement in A-T mice. This suggests that fixing mitochondrial problems by increasing mitophagy with NR could be a therapy for A-T and related aging conditions.

Journal

Aging Cell

Share

Read more

Neurological Health

Changes in NMN/NAD+ Ratio Activates SARM1 to Trigger Nerve Damage: Preclinical Findings

SynopsisAxon degeneration is a key feature of many neurodegenerative diseases. SARM1 is an enzyme that breaks down NAD+ and, when activated, causes axon destruction. The enzyme NMNAT2 normally conv...

Read more
Healthy Aging & Longevity

17-α-Estradiol Extends Male Mouse Lifespan, While Nicotinamide Riboside Shows No Significant Effect: Preclinical Findings

SynopsisIn genetically diverse mice, the “non-feminizing” estrogen 17-α-estradiol (17aE2) increased median male lifespan by 19% when started at 16 months and by 11% when started at 20 months. It al...

Read more